Sphaera is a drug discovery and development biotech, led by a team with extensive life sciences experience backed by dedicated 35,000+ square feet of R&D capabilities spanning medicinal chemistry, in-vitro and in-vivo pharmacology. Having created value for its partners, collaborators and patients by advancing multiple preclinical projects into the clinic, Sphaera is committed to provide innovative therapeutics to those who need it the most.

• Sphaera through its global collaborations, has developed platform technologies for preclinical R&D and repurposing
• Integrated drug discovery infrastructure under a single roof, with service experience and potential for new collaborations